{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:17:40Z","timestamp":1785885460587,"version":"3.56.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"name":"US Agency for International Development, the CDC,"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Division of Intramural Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background. \u2003Resistance to second-line drugs develops during treatment of multidrug-resistant (MDR) tuberculosis, but the impact on treatment outcome has not been determined.<\/jats:p>\n               <jats:p>Methods. \u2003Patients with MDR tuberculosis starting second-line drug treatment were enrolled in a prospective cohort study. Sputum cultures were analyzed at a central reference laboratory. We compared subjects with successful and poor treatment outcomes in terms of (1) initial and acquired resistance to fluoroquinolones and second-line injectable drugs (SLIs) and (2) treatment regimens.<\/jats:p>\n               <jats:p>Results. \u2003Of 1244 patients with MDR tuberculosis, 973 (78.2%) had known outcomes and 232 (18.6%) were lost to follow-up. Among those with known outcomes, treatment succeeded in 85.8% with plain MDR tuberculosis, 69.7% with initial resistance to either a fluoroquinolone or an SLI, 37.5% with acquired resistance to a fluoroquinolone or SLI, 29.3% with initial and 13.0% with acquired extensively drug-resistant tuberculosis (P &amp;lt; .001 for trend). In contrast, among those with known outcomes, treatment success increased stepwise from 41.6% to 92.3% as the number of drugs proven effective increased from \u22641 to \u22655 (P &amp;lt; .001 for trend), while acquired drug resistance decreased from 12% to 16% range, depending on the drug, down to 0%\u20132% (P &amp;lt; .001 for trend). In multivariable analysis, the adjusted odds of treatment success decreased 0.62-fold (95% confidence interval, .56\u2013.69) for each increment in drug resistance and increased 2.1-fold (1.40\u20133.18) for each additional effective drug, controlling for differences between programs and patients. Specific treatment, patient, and program variables were also associated with treatment outcome.<\/jats:p>\n               <jats:p>Conclusions. \u2003Increasing drug resistance was associated in a logical stepwise manner with poor treatment outcomes. Acquired resistance was worse than initial resistance to the same drugs. Increasing numbers of effective drugs, specific drugs, and specific program characteristics were associated with better outcomes and less acquired resistance.<\/jats:p>","DOI":"10.1093\/cid\/civ910","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T07:05:30Z","timestamp":1446015930000},"page":"418-430","source":"Crossref","is-referenced-by-count":59,"title":["Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance"],"prefix":"10.1093","volume":"62","author":[{"given":"J. Peter","family":"Cegielski","sequence":"first","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Kurbatova","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martie","family":"van der Walt","sequence":"additional","affiliation":[{"name":"Medical Research Council 3 , Pretoria ,","place":["Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Brand","sequence":"additional","affiliation":[{"name":"Medical Research Council 3 , Pretoria ,","place":["Republic of South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ershova","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma","family":"Tupasi","sequence":"additional","affiliation":[{"name":"Tropical Disease Foundation 4 , Manila ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Campos","family":"Caoili","sequence":"additional","affiliation":[{"name":"Tropical Disease Foundation 4 , Manila ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Dalton","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Contreras","sequence":"additional","affiliation":[{"name":"Socios en Salud Sucursal 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Yagui","sequence":"additional","affiliation":[{"name":"National Institute of Health 6 , Lima ,","place":["Peru"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Bayona","sequence":"additional","affiliation":[{"name":"Socios en Salud Sucursal 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Kvasnovsky","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaira","family":"Leimane","sequence":"additional","affiliation":[{"name":"Riga East University Hospital Centre of Tuberculosis and Lung Diseases 7 ,","place":["Latvia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liga","family":"Kuksa","sequence":"additional","affiliation":[{"name":"Riga East University Hospital Centre of Tuberculosis and Lung Diseases 7 ,","place":["Latvia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Chen","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Via","sequence":"additional","affiliation":[{"name":"National Institute for Allergy and Infectious Disease, National Institutes of Health 2 , Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Hee","family":"Hwang","sequence":"additional","affiliation":[{"name":"National Masan Hospital 8 , Changwon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wolfgang","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigory V.","family":"Volchenkov","sequence":"additional","affiliation":[{"name":"Vladimir Oblast Tuberculosis Dispensary 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Somova","sequence":"additional","affiliation":[{"name":"Vladimir Oblast Tuberculosis Dispensary 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Smith","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention 1 , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somsak","family":"Akksilp","sequence":"additional","affiliation":[{"name":"Ministry of Health 13 , Bangkok"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanpen","family":"Wattanaamornkiet","sequence":"additional","affiliation":[{"name":"Office of Disease Prevention and Control Region 7 14 , Ubon Ratchathani ,","place":["Thailand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Korean Institute of Tuberculosis 9 , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-ki","family":"Kim","sequence":"additional","affiliation":[{"name":"Korean Institute of Tuberculosis 9 , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris Y.","family":"Kazennyy","sequence":"additional","affiliation":[{"name":"Orel Oblast Tuberculosis Dispensary 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Khorosheva","sequence":"additional","affiliation":[{"name":"Orel Oblast Tuberculosis Dispensary 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kliiman","sequence":"additional","affiliation":[{"name":"Tartu University Hospital 15"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piret","family":"Viiklepp","sequence":"additional","affiliation":[{"name":"National Tuberculosis Registry, National Institute for Health Development, 16 Tallinn, Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwen","family":"Jou","sequence":"additional","affiliation":[{"name":"Taiwan Centers for Disease Control 17 , Taipei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Song-En","family":"Huang","sequence":"additional","affiliation":[{"name":"Taiwan Centers for Disease Control 17 , Taipei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Vasilyeva","sequence":"additional","affiliation":[{"name":"Central Tuberculosis Research Institute, Russian Academy of Medical Sciences 12 , Moscow ,","place":["Russian Federation"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Demikhova","sequence":"additional","affiliation":[{"name":"Central Tuberculosis Research Institute, Russian Academy of Medical Sciences 12 , Moscow ,","place":["Russian Federation"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Global PETTS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronel","family":"Odendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese C.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarcela","family":"Gler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswaldo","family":"Jave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Asencios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Yale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Taylor","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Norvaisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girts","family":"Skenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrida","family":"Sture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vija","family":"Riekstina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra","family":"Cirule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Sigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Nae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokyong","family":"Eum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongseok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungkyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doosoo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isdore C.","family":"Shamputa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Metchock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kuznetsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rattanawadee","family":"Akksilp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlaya","family":"Sitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirapan","family":"Inyapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Kiryanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Degtyareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia S.","family":"Nemtsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klavdia","family":"Levina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Danilovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Kummik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav V.","family":"Erokhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa N.","family":"Chernousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia N.","family":"Andreevskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena E.","family":"Larionova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana G.","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"2024111411401257800_CIV910C1","article-title":"Global tuberculosis report 2014","author":"World Health Organization","year":"2014"},{"key":"2024111411401257800_CIV910C2","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs\u2014worldwide, 2000\u20132004","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR"},{"key":"2024111411401257800_CIV910C3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3201\/eid1303.061400","article-title":"Worldwide emergence of extensively drug-resistant tuberculosis","volume":"13","author":"Shah","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2024111411401257800_CIV910C4","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","article-title":"Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study","volume":"380","author":"Dalton","year":"2012","journal-title":"Lancet"},{"key":"2024111411401257800_CIV910C5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/am.20.5.810-814.1970","article-title":"Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis","volume":"20","author":"David","year":"1970","journal-title":"Appl Microbiol"},{"key":"2024111411401257800_CIV910C6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/cid\/ciu572","article-title":"Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis","volume":"59","author":"Cegielski","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411401257800_CIV910C7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1164\/rccm.200911-1768OC","article-title":"Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment","volume":"182","author":"Shin","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2024111411401257800_CIV910C8","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/cid\/cis748","article-title":"Acquired resistance to second-line drugs among persons with tuberculosis in the United States","volume":"55","author":"Ershova","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2024111411401257800_CIV910C9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.5588\/ijtld.11.0696","article-title":"Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002\u20132005","volume":"16","author":"Cavanaugh","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024111411401257800_CIV910C10","volume-title":"Public health mycobacteriology a guide for the level III laboratory","author":"Kent","year":"1985"},{"key":"2024111411401257800_CIV910C11","article-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard","author":"Clinical and Laboratory Standards Institute","year":"2011","edition":"2nd ed"},{"key":"2024111411401257800_CIV910C12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/JCM.40.5.1592-1602.2002","article-title":"Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units","volume":"40","author":"Cowan","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2024111411401257800_CIV910C13","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/JCM.01392-06","article-title":"Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis","volume":"44","author":"Supply","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2024111411401257800_CIV910C14","first-page":"640","article-title":"Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis","volume":"9","author":"Laserson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024111411401257800_CIV910C15","article-title":"Guidelines for the programmatic management of drug-resistant tuberculosis","author":"World Health Organization","year":"2008"},{"key":"2024111411401257800_CIV910C16","doi-asserted-by":"crossref","first-page":"e108035","DOI":"10.1371\/journal.pone.0108035","article-title":"Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment","volume":"9","author":"Tierney","year":"2014","journal-title":"PLoS One"},{"key":"2024111411401257800_CIV910C17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciu209","article-title":"Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death","volume":"59","author":"Vel\u00e1squez","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411401257800_CIV910C18","doi-asserted-by":"crossref","first-page":"e58664","DOI":"10.1371\/journal.pone.0058664","article-title":"Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality","volume":"8","author":"Mitnick","year":"2013","journal-title":"PLoS One"},{"key":"2024111411401257800_CIV910C19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/cid\/cis1008","article-title":"Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence","volume":"56","author":"Franke","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024111411401257800_CIV910C20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cid\/ciu372","article-title":"Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993\u20132008","volume":"59","author":"Ershova","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411401257800_CIV910C21","doi-asserted-by":"crossref","first-page":"e1001300","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Med"},{"key":"2024111411401257800_CIV910C22","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/ciu619","article-title":"Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis","volume":"59","author":"Bastos","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2024111411401257800_CIV910C23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2013","journal-title":"Eur Respir J"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/62\/4\/418\/16788157\/civ910.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/62\/4\/418\/16788157\/civ910.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:48:05Z","timestamp":1731584885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/62\/4\/418\/2462715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,10,27]]},"published-print":{"date-parts":[[2016,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ910","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,2,15]]},"published":{"date-parts":[[2015,10,27]]}}}